Novartis Could Be On Hook For Generic Drug: Calif. Justices

By Emily Field (December 21, 2017, 9:36 PM EST) -- The California Supreme Court on Thursday said brand-name drugmaker Novartis could be held liable for negligent misrepresentation and failure to warn of the alleged dangers of a generic version of one of its drugs, saying its liability doesn't end after it sells the rights to the drug.

The state high court upheld a lower court's decision that Novartis AG could be a defendant in the suit brought by twins who claim their autism stems from their mother ingesting a generic version of Novartis' name-brand asthma medication Brethine. The California Supreme Court said that only a brand-name manufacturer has unilateral authority to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!